Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC/IT-TOF MS
- PMID: 24228263
Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC/IT-TOF MS
Abstract
In this study, an ultra fast LC/IT-TOF MS (UFLC/IT-TOF MS)-based serum lipidomics method was employed to characterize the serum lipid profile of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma (HCC). After data collection and processing, 96 lipids including lysophosphatidylcholines, phosphatidylcholines, sphingomyelins, triacylglycerides, and cholesterol esters were identified and used for subsequent data analysis. Partial least squares-discriminant analysis revealed that patients with liver diseases had distinctly different serum lipid profile from that of healthy controls; while cirrhosis and HCC patients had a similar serum lipid profile, but different from that of hepatitis patients. The ANOVA analysis found 75 of the 96 identified lipids to be abnormally regulated, among which most of these lipids were downregulated in cirrhosis and HCC patients compared with those of healthy controls and hepatitis patients, while hepatitis patients induced several lipids downregulated and others upregulated compared with those of healthy controls, indicating the aberrant lipid metabolism in patients with liver diseases. This work demonstrated the utility of UFLC/IT-TOF MS-based serum lipidomics as a powerful tool to investigate the lipid metabolism of liver diseases.
Similar articles
-
Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography-mass spectrometry.BMC Cancer. 2015 Dec 18;15:985. doi: 10.1186/s12885-015-1995-1. BMC Cancer. 2015. PMID: 26680993 Free PMC article.
-
Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.Biochem Biophys Res Commun. 2012 Apr 6;420(2):308-14. doi: 10.1016/j.bbrc.2012.02.155. Epub 2012 Mar 7. Biochem Biophys Res Commun. 2012. PMID: 22425980
-
Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry.J Proteome Res. 2012 Nov 2;11(11):5433-42. doi: 10.1021/pr300683a. Epub 2012 Sep 28. J Proteome Res. 2012. PMID: 22946841
-
Natural history of chronic hepatitis B REVEALed.J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. J Gastroenterol Hepatol. 2011. PMID: 21323729 Review.
-
Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma.Biochim Biophys Acta Mol Cell Biol Lipids. 2020 May;1865(5):158658. doi: 10.1016/j.bbalip.2020.158658. Epub 2020 Feb 10. Biochim Biophys Acta Mol Cell Biol Lipids. 2020. PMID: 32058031 Review.
Cited by
-
Serum Phosphatidylcholine Species 32:0 as a Biomarker for Liver Cirrhosis Pre- and Post-Hepatitis C Virus Clearance.Int J Mol Sci. 2024 Jul 26;25(15):8161. doi: 10.3390/ijms25158161. Int J Mol Sci. 2024. PMID: 39125730 Free PMC article.
-
Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry.Trends Analyt Chem. 2014 Oct 1;61:192-206. doi: 10.1016/j.trac.2014.04.017. Trends Analyt Chem. 2014. PMID: 25309011 Free PMC article.
-
Integrative analysis of saliva-derived exosomal proteome and lipidome for the diagnosis of esophageal squamous cell carcinoma.BMC Cancer. 2025 Aug 1;25(1):1254. doi: 10.1186/s12885-025-14452-x. BMC Cancer. 2025. PMID: 40751234 Free PMC article.
-
Role of triglycerides as a predictor of autoimmune hepatitis with cirrhosis.Lipids Health Dis. 2022 Oct 25;21(1):108. doi: 10.1186/s12944-022-01716-9. Lipids Health Dis. 2022. PMID: 36284329 Free PMC article.
-
Discriminatory Changes in Circulating Metabolites as a Predictor of Hepatocellular Cancer in Patients with Metabolic (Dysfunction) Associated Fatty Liver Disease.Liver Cancer. 2022 Jul 8;12(1):19-31. doi: 10.1159/000525911. eCollection 2023 Feb. Liver Cancer. 2022. PMID: 36872928 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical